Hester Bios

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE782E01017
  • NSEID: HESTERBIO
  • BSEID: 524669
INR
2,049.30
-4.8 (-0.23%)
BSENSE

Jun 18

BSE+NSE Vol: 10.37 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 324228,
    "name": "Hester Bios",
    "stock_name": "Hester Bios",
    "full_name": "Hester Biosciences Ltd",
    "name_url": "stocks-analysis/hester-bios",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "2,049.30",
    "chg": -4.8,
    "chgp": "-0.23%",
    "dir": -1,
    "prev_price": "2,054.10",
    "mcapval": "1,763.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 524669,
    "symbol": "HESTERBIO",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE782E01017",
    "curr_date": "Jun 18",
    "curr_time": "",
    "bse_nse_vol": "10.37 k",
    "exc_status": "Active",
    "traded_date": "Jun 18, 2026",
    "traded_date_str": "2026 06 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswaluat.com/MOSL-Landingstocks-analysis/hester-bios-324228-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Hester Biosciences consolidated net profit rises 1138.76% in the March 2026 quarter",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-05-15 14:22:07",
        "description": "Hester Biosciences consolidated net profit rises 1138.76% in the March 2026 quarter  Business Standard..."
      }
    ],
    "total": 1,
    "sid": "324228",
    "stock_news_url": "https://marketsmojo.motilaloswaluat.com/news/hester-biosciences-324228"
  },
  "announcements": [
    {
      "caption": "Announcement Under Regulation 30 Of Listing Regulations - Disclosure On Amendments In Loan Agreement Of Hester Africa",
      "datetime": "20-May-2026",
      "details": "Announcement under Regulation 30 of Listing Regulation - Amendments in Loan agreement of Hester Africa",
      "source": "BSE"
    },
    {
      "caption": "Intimation Of Submission Of The Reclassification Application Under Regulation 31A Of Listing Regulations",
      "datetime": "20-May-2026",
      "details": "Intimation of Submission of reclassification application with the stock exchanges under Regulations 31A of Listing Regulations",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
      "datetime": "18-May-2026",
      "details": "Annual Secretarial Compliance Report for the year ended 31 March 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Hester Biosciences Ltd has declared <strong>70%</strong> dividend, ex-date: 06 Aug 25",
          "dt": "2025-08-06",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Hester Biosciences Ltd has announced <strong>1:2</strong> bonus issue, ex-date: 27 Sep 12",
          "dt": "2012-09-27",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Hester Biosciences Ltd has announced <strong>2:5</strong> rights issue, ex-date: 29 May 06",
          "dt": "2006-05-29",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}
stock-recommendationAnnouncement

Announcement Under Regulation 30 Of Listing Regulations - Disclosure On Amendments In Loan Agreement Of Hester Africa

20-May-2026 | Source : BSE

Announcement under Regulation 30 of Listing Regulation - Amendments in Loan agreement of Hester Africa

Intimation Of Submission Of The Reclassification Application Under Regulation 31A Of Listing Regulations

20-May-2026 | Source : BSE

Intimation of Submission of reclassification application with the stock exchanges under Regulations 31A of Listing Regulations

Compliances-Reg.24(A)-Annual Secretarial Compliance

18-May-2026 | Source : BSE

Annual Secretarial Compliance Report for the year ended 31 March 2026

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Hester Biosciences Ltd has declared 70% dividend, ex-date: 06 Aug 25

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

Hester Biosciences Ltd has announced 1:2 bonus issue, ex-date: 27 Sep 12

stock-summary
RIGHTS

Hester Biosciences Ltd has announced 2:5 rights issue, ex-date: 29 May 06